Patients with bladder cancer need frequent controls over long follow-up time due to high recurrence rate and risk of conversion to muscle invasive cancer with poor prognosis. We identified cancer-related molecular signatures in apparently healthy bladder in patients with subsequent muscular invasiveness during follow-up. Global proteomics of the normal tissue biopsies revealed specific proteome fingerprints in these patients prior to subsequent muscular invasiveness. In these presumed normal samples, we detected modulations of proteins previously associated with different cancer types. This study indicates that analyzing apparently healthy tissue of a cancer-invaded organ may suggest disease progression.</div
Introduction: Although several molecular markers for bladder cancer have been identified, at present...
Secreted proteins play a key role in cell signaling, communication and migration. We recently descri...
Background: Proteomic discovery of cancer biomarkers in body fluids is challenging because of their ...
Patients with bladder cancer need frequent controls over long follow-up time due to high recurrence ...
Background: Bladder cancer is a life-threatening disease and a major cause of cancer-associated comp...
Bladder cancer (BC) is the most common tumor of the urinary tract and is conventionally classified a...
This study aimed to detect protein changes that can assist to understand the underlying biology of b...
Bladder cancer is the 10th most common cancer in the world [1]. It is the 6th most common amongst me...
Muscle-invasive bladder cancer is a heterogeneous disease with different clinical phenotypes. Histom...
Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disrup-tions and al...
Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disruptions and alt...
Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disruptions and alt...
Patients with advanced bladder cancer have poor outcomes, indicating a need for more efficient thera...
Urinary bladder cancer is a heterogeneous disease appearing in different forms, e.g. non-muscle inva...
<div><p>The best way to increase patient survival rate is to identify patients who are likely to pro...
Introduction: Although several molecular markers for bladder cancer have been identified, at present...
Secreted proteins play a key role in cell signaling, communication and migration. We recently descri...
Background: Proteomic discovery of cancer biomarkers in body fluids is challenging because of their ...
Patients with bladder cancer need frequent controls over long follow-up time due to high recurrence ...
Background: Bladder cancer is a life-threatening disease and a major cause of cancer-associated comp...
Bladder cancer (BC) is the most common tumor of the urinary tract and is conventionally classified a...
This study aimed to detect protein changes that can assist to understand the underlying biology of b...
Bladder cancer is the 10th most common cancer in the world [1]. It is the 6th most common amongst me...
Muscle-invasive bladder cancer is a heterogeneous disease with different clinical phenotypes. Histom...
Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disrup-tions and al...
Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disruptions and alt...
Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disruptions and alt...
Patients with advanced bladder cancer have poor outcomes, indicating a need for more efficient thera...
Urinary bladder cancer is a heterogeneous disease appearing in different forms, e.g. non-muscle inva...
<div><p>The best way to increase patient survival rate is to identify patients who are likely to pro...
Introduction: Although several molecular markers for bladder cancer have been identified, at present...
Secreted proteins play a key role in cell signaling, communication and migration. We recently descri...
Background: Proteomic discovery of cancer biomarkers in body fluids is challenging because of their ...